TN SB0048 | 2025-2026 | 114th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 9 2025 - 25% progression
Action: 2025-01-14 - Introduced, Passed on First Consideration
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on January 9 2025 - 25% progression
Action: 2025-01-14 - Introduced, Passed on First Consideration
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., and Sun Pharmaceutical Industries, Inc. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Title
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2025-01-14 | Senate | Introduced, Passed on First Consideration |
2025-01-09 | Senate | Filed for introduction |
Subjects
Tennessee State Sources
Type | Source |
---|---|
Summary | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=SB0048&ga=114 |
Text | https://www.capitol.tn.gov/Bills/114/Bill/SB0048.pdf |